Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • ACA Enrollment
  • Ebola
  • PFAS in Drinking Water
  • Drug-Related Driving Deaths
  • Black Maternal Health

WHAT'S NEW

  • ACA Enrollment
  • Ebola
  • PFAS in Drinking Water
  • Drug-Related Driving Deaths
  • Black Maternal Health

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Jan 9 2020

Full Issue

OxyContin Sales Reps Had Ready Answers When Faced With Doctors' Growing Concerns About Opioid Addiction

New documents support growing evidence that concerns about misuse raised even in the early days of the epidemic were countered time and again by Purdue Pharma sales reps. Other news on the opioid epidemic looks at needle exchanges, addiction treatment providers, HIV infections, and more.

Stat: Faced With Fears Of OxyContin Misuse, Sales Reps Touted Its Safety 

A year and a half after the opioid painkiller OxyContin went on the market, a Purdue Pharma sales representative documented a physician’s concern about the burgeoning drug that would come up again and again. “Dr worried re addiction w/ Oxy,” the sales rep wrote in a memo summarizing a visit with a Kentucky physician on Aug. 12, 1997. The representative had a ready message to deflect such concerns: “Oxy is long-acting, has fewer peaks than other oxycodone combos, less addictive value.” (Joseph and Chakradhar, 1/9)

Tampa Bay Times: Hillsborough Takes First Steps Toward Needle Exchange Pilot Program

With the county commission now on board, Hillsborough is on track to become one of the first counties in Florida to take advantage of a new state law allowing local governments to offer free, clean syringes in exchange for used ones. The commission gave its first nod of approval Wednesday to a proposed pilot needle exchange program that would not only provide free hypodermic needles to the community, but also offer on-site medical treatment, mental health counseling and access to the overdose-reversing drug Narcan. (Dawson, 1/8)

Boston Globe: Federal Database Of Addiction Treatment Providers Outdated, Study Finds

There’s a rallying cry heard often in the battle against opioid addiction: People with opioid dependence need immediate access to treatment, particularly the medications that stop cravings and prevent overdoses. But a study published this week in the Journal of Psychiatric Practice found that one avenue to addiction treatment — a federal database of clinicians who prescribe buprenorphine, a key antiaddiction medication — is rife with inaccuracies and unlikely to connect patients with care. (Freyer, 1/8)

Boston Globe: State Moves To Prevent Surge In HIV Infections Among Homeless Drug Users

State officials on Wednesday alerted Boston-area health care providers about a growing risk of HIV infections, asking for enhanced vigilance after seven new cases were identified recently among homeless people who inject drugs. Those cases, most diagnosed in December, are among 25 HIV infections in an outbreak first recognized a year ago, stirring concerns about a deadly consequence of the opioid epidemic. The 25 individuals are people who inject drugs, have recently experienced homelessness, and have sought medical care in Boston. (Freyer, 1/8)

WBUR: The Case For Sending Drug Users Home With PICC Lines

Finishing IV antibiotic treatment at home has become standard protocol for patients like Jackson with a serious bacterial infection. Except that Jackson, who is 69, was addicted to heroin for 40 years. Sending someone with a history of injection drug use home with an open line into a major vein is just not done in the U.S., except at a handful of hospitals. Brigham and Women’s is now one of them. (Bebinger, 1/9)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, May 20
  • Tuesday, May 19
  • Monday, May 18
  • Friday, May 15
  • Thursday, May 14
  • Wednesday, May 13
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF